Literature DB >> 31268676

Toxoplasmosis and Psychiatric and Neurological Disorders: A Step toward Understanding Parasite Pathogenesis.

Haitham G Abo-Al-Ela1.   

Abstract

Toxoplasmosis, a disease that disrupts fetal brain development and severely affects the host's brain, has been linked to many behavioral and neurological disorders. There is growing interest in how a single-celled neurotropic parasite, Toxoplasma gondii, can control or change the behavior of the host as well as how it dominates the host's neurons. Secrets beyond these could be answered by decoding the Toxoplasma gondii genome, unravelling the function of genomic sequences, and exploring epigenetics and mRNAs alterations, as well as the postulated mechanisms contributing to various neurological and psychiatric symptoms caused by this parasite. Substantial efforts have been made to elucidate the action of T. gondii on host immunity and the biology of its infection. However, the available studies on the molecular aspects of toxoplasmosis that affect central nervous system (CNS) circuits remain limited, and much research is still needed on this interesting topic. In my opinion, this parasite is a gift for studying the biology of the nervous system and related diseases. We should utilize the unique features of Toxoplasma, such as its abilities to modulate brain physiology, for neurological studies or as a possible tool or approach to cure neurological disease.

Entities:  

Keywords:  Apicomplexa; Toxoplasma gondii; behavioral disorder; mental health; personality changes; toxoplasmosis; transcripts change

Mesh:

Year:  2019        PMID: 31268676     DOI: 10.1021/acschemneuro.9b00245

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  6 in total

Review 1.  The emerging regulatory roles of noncoding RNAs in immune function of fish: MicroRNAs versus long noncoding RNAs.

Authors:  Haitham G Abo-Al-Ela
Journal:  Mol Genet Genomics       Date:  2021-04-27       Impact factor: 3.291

2.  Inhibition of Toxoplasma gondii Growth by Dihydroquinine and Its Mechanisms of Action.

Authors:  Aarin M Huffman; Joseph A Ayariga; Audrey Napier; Boakai K Robertson; Daniel A Abugri
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

Review 3.  Toxoplasmosis: Targeting neurotransmitter systems in psychiatric disorders.

Authors:  Tooran Nayeri; Shahabeddin Sarvi; Ahmad Daryani
Journal:  Metab Brain Dis       Date:  2021-09-03       Impact factor: 3.584

4.  Imiquimod Targets Toxoplasmosis Through Modulating Host Toll-Like Receptor-MyD88 Signaling.

Authors:  Maguy Hamie; Rania Najm; Carine Deleuze-Masquefa; Pierre Antoine Bonnet; Jean-François Dubremetz; Marwan El Sabban; Hiba El Hajj
Journal:  Front Immunol       Date:  2021-03-09       Impact factor: 7.561

Review 5.  NAD+ Metabolism, Metabolic Stress, and Infection.

Authors:  Benjamin Groth; Padmaja Venkatakrishnan; Su-Ju Lin
Journal:  Front Mol Biosci       Date:  2021-05-19

6.  High Prevalence of Toxoplasma gondii Infection in Type I Diabetic Patients.

Authors:  Qasem Asgari; Mohammad Hossein Motazedian; Amir Khazanchin; Davood Mehrabani; Shahrbanou Naderi Shahabadi
Journal:  J Parasitol Res       Date:  2021-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.